These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20499474)

  • 61. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
    Ault K; Reisinger K
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Measuring serum antibody to human papillomavirus following infection or vaccination.
    Frazer IH
    Gynecol Oncol; 2010 Jun; 118(1 Suppl):S8-11. PubMed ID: 20494221
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Global stability of equilibria in a two-sex HPV vaccination model.
    Elbasha EH
    Bull Math Biol; 2008 Apr; 70(3):894-909. PubMed ID: 17999117
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HPV 6, 11, 16, 18 vaccine in men. Inadequate assessment.
    Prescrire Int; 2012 Sep; 21(130):208. PubMed ID: 23016251
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [HPV vaccination].
    Stronski Huwiler S; Spaar A
    Ther Umsch; 2016; 73(5):241-6. PubMed ID: 27268446
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Practical implementation of HPV vaccines in clinical practice.
    Kimmel SR
    J Fam Pract; 2006 Nov; Suppl():18-22. PubMed ID: 17366754
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HPV vaccine and males: issues and challenges.
    Zimet GD; Rosenthal SL
    Gynecol Oncol; 2010 May; 117(2 Suppl):S26-31. PubMed ID: 20129653
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls.
    Lindley MC; Jeyarajah J; Yankey D; Curtis CR; Markowitz LE; Stokley S
    Hum Vaccin Immunother; 2016 Jun; 12(6):1519-27. PubMed ID: 27003108
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recommendations of the Polish Society of HPV Infections Prophylaxis - (PS-HPVIP) (Polskie towarzystwo profilaktyki zakazen HPV - PTPZ-HPV) concerning the use of preventive vaccines against HPV.
    Majewski S; Wysocki J; Sikorski M; Niemiec T; Jackowska T;
    Med Wieku Rozwoj; 2008; 12(2 Pt 1):621-5, 627-31. PubMed ID: 19301511
    [No Abstract]   [Full Text] [Related]  

  • 71. Human papillomavirus vaccine for women over forty: it's not just for kids.
    Mayer AP; Vegunta S; Files JA
    J Womens Health (Larchmt); 2012 Sep; 21(9):982-3. PubMed ID: 22816506
    [No Abstract]   [Full Text] [Related]  

  • 72. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation on the persistence of anti-HPV immune responses to the quadrivalent HPV vaccine in Chinese females and males: Up to 3.5 years of follow-up.
    Huang T; Liu Y; Li Y; Liao Y; Shou Q; Zheng M; Liao X; Li R
    Vaccine; 2018 Mar; 36(11):1368-1374. PubMed ID: 29428178
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human papillomavirus vaccine introduction--the first five years.
    Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
    Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety of HPV vaccination: a FIGO statement.
    Denny L;
    Int J Gynaecol Obstet; 2013 Dec; 123(3):187-8. PubMed ID: 24139200
    [No Abstract]   [Full Text] [Related]  

  • 76. Factors associated with completion of the human papillomavirus vaccine series.
    Neubrand TP; Breitkopf CR; Rupp R; Breitkopf D; Rosenthal SL
    Clin Pediatr (Phila); 2009 Nov; 48(9):966-9. PubMed ID: 19483128
    [No Abstract]   [Full Text] [Related]  

  • 77. Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.
    Herweijer E; Ploner A; Sparén P
    Vaccine; 2018 Apr; 36(15):1917-1920. PubMed ID: 29523448
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human papillomavirus vaccine uptake: what works and what can we do better?
    Lavelanet AF; Stampler KM; Dunton CJ
    J Low Genit Tract Dis; 2015 Jan; 19(1):e17-22. PubMed ID: 24769649
    [No Abstract]   [Full Text] [Related]  

  • 79. Assessment of HPV vaccines: from the burden of disease to the health technology assessment approach.
    La Torre G
    Hum Vaccin; 2010 Nov; 6(11):915-7. PubMed ID: 20980798
    [No Abstract]   [Full Text] [Related]  

  • 80. Human papillomavirus vaccinations matter!
    van der Sande MAB; van der Loeff MFS
    Lancet Infect Dis; 2021 Oct; 21(10):1341-1342. PubMed ID: 34043962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.